Press Release Description

Global Topical Pain Relief market is anticipated to grow at a CAGR of around 7.5% during 2021-26

The Global Topical Pain Relief Market is robustly growing due to the rising incidence of arthritis, chronic diseases, and diabetic neuropathy among people entwined with the booming elderly population. Moreover, the soaring demand for pain relief products among sports people to seek relief from muscular pains, including neck, shoulder, and back pain and strain, also propels the overall market. Besides, their easy availability through online pharmacies and the launch of the new innovative products are other critical factors likely to escalate the demand for topical pain relief products in the forecast period.

Global Topical Pain Relief Market Share

Key questions answered in the study:

  1. What are the current and future trends of the Topical Pain Relief industry?
  2. How has the market been evolving in terms of end-user demand and application areas?
  3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
  4. What are the key growth drivers and challenges for the Topical Pain Relief industry?
  5. What are customer orientation, purchase behavior, and expectations from the Topical Pain Relief firms across various regions?

According to MarkNtel Advisors’ research report, “Global Topical Pain Relief Market Analysis, 2021,” the market is likely to grow at a CAGR of around 7.5% during 2021-26. Based on Formulation, the Gel segment acquired a significant market share in the previous years. The demand for gel-based body pain products is surging as gel gets absorbed quickly into the skin and works effectively on muscular pain. Besides, the surging number of gel-based topical pain relief product launches by market players are amongst other critical aspects likely to fuel the overall market growth.

“Global Topical Pain Relief Market Analysis, 2021” provides comprehensive, qualitative, and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Topical Pain Relief providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which would help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings.

North America Dominated the Market 

North America dominated the Global Topical Pain Relief Market in the previous few years due to the significantly rising number of genetic counselors. The US acquired the majority market share in North America due to the rising number of launches of innovative products like fast relief gels & patches, increasing adoption of meditations over oral medications for pain management, and growing prevalence of musculoskeletal injuries among people. MSDs are among the most common causes of severe long-term pain and physical disability in the US. Hence, this factor shall also surge the Global Topical Pain Relief market in the region, states MarkNtel Advisors in their research report, “Global Topical Pain Relief Market Analysis, 2021.”

According to MarkNtel Advisors, the key players with a considerable market share in the Global Topical Pain Relief market are AdvaCare Pharma, GlaxoSmithKline plc., Sanofi, Johnson & Johnson, Novartis AG, Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Topical BioMedics, Inc. (Topricin), Exzell Pharma, and Emami Group.

Market Segmentation:

  1. By Type (Prescription Pain Relief, Over-The-Counter Pain Relief)
  2. By Therapeutic Class (Non-Opioids [Nonsteroidal Anti-Inflammatory Drug, Methyl Salicylate, Capsaicin, Lidocaine], Opioids [Buprenorphine and Fentanyl])
  3. By Formulation (Cream, Gel, Spray, Patch)
  4. By Distribution Channel (Pharmacy Drug Store, E-Commerce, Others)
  5. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
  6. By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Italy, Spain, China, Japan, South Korea, India, Australia, New Zealand, UAE, Saudi Arabia, South Africa),
  7. By Company (AdvaCare Pharma, GlaxoSmithKline plc., Sanofi, Johnson & Johnson, Novartis AG, Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Topical BioMedics, Inc. (Topricin), Exzell Pharma, Emami Group)